195 related articles for article (PubMed ID: 30198521)
1. Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization.
Zavrelova A; Paterova P; Gabalec F; Zak P; Radocha J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):161-165. PubMed ID: 30198521
[TBL] [Abstract][Full Text] [Related]
2. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Satlin MJ; Vardhana S; Soave R; Shore TB; Mark TM; Jacobs SE; Walsh TJ; Gergis U
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1808-14. PubMed ID: 26150022
[TBL] [Abstract][Full Text] [Related]
3. Addition of doxycycline to ciprofloxacin for infection prophylaxis during autologous stem cell transplants for multiple myeloma.
Sivik JM; Davidson J; Hale CM; Drabick JJ; Talamo G
Support Care Cancer; 2018 Sep; 26(9):3055-3061. PubMed ID: 29564621
[TBL] [Abstract][Full Text] [Related]
4. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
Copeland V; McLaughlin M; Trifilio S
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29080369
[TBL] [Abstract][Full Text] [Related]
6. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look.
Maakaron JE; Liscynesky C; Boghdadly ZE; Huang Y; Agyeman A; Brammer J; Penza S; Efebera Y; Benson D; Rosko A; William B; Jaglowski SM
Biol Blood Marrow Transplant; 2020 Aug; 26(8):e198-e201. PubMed ID: 32304873
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.
Yeshurun M; Vaxman I; Shargian L; Yahav D; Bishara J; Pasvolsky O; Wolach O; Lahav M; Gurion R; Magen H; Vidal L; Herscovici C; Peck A; Moshe M; Sela-Navon M; Naparstek E; Raanani P; Rozovski U
Clin Microbiol Infect; 2018 Jul; 24(7):749-754. PubMed ID: 29208561
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C
Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366
[TBL] [Abstract][Full Text] [Related]
11. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Ali N; Adil SN; Shaikh MU
Transpl Infect Dis; 2014 Feb; 16(1):98-105. PubMed ID: 24383473
[TBL] [Abstract][Full Text] [Related]
12. Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
Kim JH; Goulston C; Zangari M; Tricot G; Boyer MW; Hanson KE
Transpl Infect Dis; 2014 Jun; 16(3):421-9. PubMed ID: 24797543
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of fluoroquinolone prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation.
Simondsen KA; Reed MP; Mably MS; Zhang Y; Longo WL
J Oncol Pharm Pract; 2013 Dec; 19(4):291-7. PubMed ID: 23184539
[TBL] [Abstract][Full Text] [Related]
14. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
[TBL] [Abstract][Full Text] [Related]
15. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
[TBL] [Abstract][Full Text] [Related]
16. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
17. Drug monitoring during ciprofloxacin prophylaxis of allogeneic stem cell transplant patients: associations with bacterial infections through a monocentric observational prospective study.
Kaba HEJ; Hasenkamp J; Tas H; Schulz M; Streit F; Eiffert H; Wulf G; Truemper L; Binder L; Kaase M; Scheithauer S
J Hosp Infect; 2024 Jan; 143():160-167. PubMed ID: 37939885
[TBL] [Abstract][Full Text] [Related]
18. Bacteraemia post-autologous haematopoietic stem cell transplantation in the absence of antibacterial prophylaxis: a decade's experience from Lebanon.
Moghnieh R; Abdallah D; Awad L; Jisr T; Mugharbil A; Youssef A; Tamim H; Khaldieh S; Massri O; Rashini N; Hamdan Y; Ibrahim A
Infection; 2018 Dec; 46(6):823-835. PubMed ID: 30143988
[TBL] [Abstract][Full Text] [Related]
19. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
Przybylski DJ; Reeves DJ
Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
[TBL] [Abstract][Full Text] [Related]
20. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
Lee DG; Choi SM; Choi JH; Yoo JH; Park YH; Kim YJ; Lee S; Min CK; Kim HJ; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Korean J Intern Med; 2002 Mar; 17(1):38-44. PubMed ID: 12014211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
